1. Home
  2. AFMD vs CCG Comparison

AFMD vs CCG Comparison

Compare AFMD & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • CCG
  • Stock Information
  • Founded
  • AFMD 2000
  • CCG 2014
  • Country
  • AFMD Germany
  • CCG China
  • Employees
  • AFMD N/A
  • CCG N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • AFMD Health Care
  • CCG
  • Exchange
  • AFMD Nasdaq
  • CCG Nasdaq
  • Market Cap
  • AFMD 77.2M
  • CCG 78.0M
  • IPO Year
  • AFMD 2014
  • CCG N/A
  • Fundamental
  • Price
  • AFMD $3.31
  • CCG $0.79
  • Analyst Decision
  • AFMD Strong Buy
  • CCG
  • Analyst Count
  • AFMD 5
  • CCG 0
  • Target Price
  • AFMD $16.25
  • CCG N/A
  • AVG Volume (30 Days)
  • AFMD 94.1K
  • CCG 416.1K
  • Earning Date
  • AFMD 11-12-2024
  • CCG 08-29-2024
  • Dividend Yield
  • AFMD N/A
  • CCG N/A
  • EPS Growth
  • AFMD N/A
  • CCG N/A
  • EPS
  • AFMD N/A
  • CCG N/A
  • Revenue
  • AFMD $7,959,927.00
  • CCG $458,246,707.00
  • Revenue This Year
  • AFMD N/A
  • CCG N/A
  • Revenue Next Year
  • AFMD $48.98
  • CCG N/A
  • P/E Ratio
  • AFMD N/A
  • CCG N/A
  • Revenue Growth
  • AFMD N/A
  • CCG 6.42
  • 52 Week Low
  • AFMD $2.24
  • CCG $0.56
  • 52 Week High
  • AFMD $8.95
  • CCG $10.00
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 43.88
  • CCG 49.95
  • Support Level
  • AFMD $2.92
  • CCG $0.75
  • Resistance Level
  • AFMD $3.32
  • CCG $0.83
  • Average True Range (ATR)
  • AFMD 0.13
  • CCG 0.09
  • MACD
  • AFMD 0.04
  • CCG 0.00
  • Stochastic Oscillator
  • AFMD 75.38
  • CCG 34.30

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About CCG Cheche Group Inc.

Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.

Share on Social Networks: